SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-22-008160
Filing Date
2022-01-13
Accepted
2022-01-13 07:23:32
Documents
12
Period of Report
2022-01-12
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

Document Format Files

Seq Description Document Type Size
1 8-K d280151d8k.htm   iXBRL 8-K 23191
  Complete submission text file 0001193125-22-008160.txt   145409

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA fmtx-20220112.xsd EX-101.SCH 2918
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE fmtx-20220112_lab.xml EX-101.LAB 18138
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE fmtx-20220112_pre.xml EX-101.PRE 11425
6 EXTRACTED XBRL INSTANCE DOCUMENT d280151d8k_htm.xml XML 3373
Mailing Address 300 NORTH BEACON STREET SUITE 501 WATERTOWN MA 02472
Business Address 300 NORTH BEACON STREET SUITE 501 WATERTOWN MA 02472 617-679-1970
Forma Therapeutics Holdings, Inc. (Filer) CIK: 0001538927 (see all company filings)

IRS No.: 371657129 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39333 | Film No.: 22527846
SIC: 2836 Biological Products, (No Diagnostic Substances)